253 related articles for article (PubMed ID: 28980065)
1. Conservative endovascular management of retained placenta accreta with marked vascularity after abortion or delivery.
Takeda A; Koike W
Arch Gynecol Obstet; 2017 Dec; 296(6):1189-1198. PubMed ID: 28980065
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of placenta accreta: hysteroscopic resection of retained tissues.
Legendre G; Zoulovits FJ; Kinn J; Senthiles L; Fernandez H
J Minim Invasive Gynecol; 2014; 21(5):910-3. PubMed ID: 24768979
[TBL] [Abstract][Full Text] [Related]
3. Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accreta.
Hequet D; Morel O; Soyer P; Gayat E; Malartic C; Barranger E
Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):580-3. PubMed ID: 24138386
[TBL] [Abstract][Full Text] [Related]
4. Uterine artery embolization and hysteroscopic resection to treat retained placenta accreta: A case report.
Greenberg JA; Miner JD; O'Horo SK
J Minim Invasive Gynecol; 2006; 13(4):342-4. PubMed ID: 16825079
[TBL] [Abstract][Full Text] [Related]
5. High-intensity focused ultrasound combined procedures treatment of retained placenta accreta with marked vascularity after abortion or delivery.
Jiang X; Tang Q; Yang B; Ye F; Cai L; Wang X; Luo X; Bu H
Int J Hyperthermia; 2019; 36(1):421-427. PubMed ID: 30892148
[TBL] [Abstract][Full Text] [Related]
6. Conservative management of placenta increta after first trimester abortion by transcatheter arterial chemoembolization: a case report and review of the literature.
Takeda A; Koyama K; Imoto S; Mori M; Nakano T; Nakamura H
Arch Gynecol Obstet; 2010 Mar; 281(3):381-6. PubMed ID: 19777249
[TBL] [Abstract][Full Text] [Related]
7. [PROLONGED RETAINED PLACENTA ACCRETA IN THE UTERUS AFTER VAGINAL DELIVERY (A CASE REPORT AND REVIEW OF LITERATURE)].
Nashar SV; Dimitrova V; Zlatkov V; Frandeva B; Dimitrov A
Akush Ginekol (Sofiia); 2015; 54(3):34-9. PubMed ID: 26137778
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of placenta accreta.
Hatfield JL; Brumsted JR; Cooper BC
J Minim Invasive Gynecol; 2006; 13(6):510-3. PubMed ID: 17097571
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation.
Chou MM; Yuan JC; Lu YA; Chuang SW
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):952-955. PubMed ID: 33218420
[TBL] [Abstract][Full Text] [Related]
10. Utility of the pulsatility index of the uterine arteries and human chorionic gonadotropin in a series of cases of placenta accreta.
Dueñas-Garcia OF; Diaz-Sotomayor M; Rico-Olvera H
J Obstet Gynaecol Res; 2011 Aug; 37(8):1112-6. PubMed ID: 21463424
[TBL] [Abstract][Full Text] [Related]
11. Is the cold loop hysteroscopic technique a myometrial sparing treatment for placenta accreta residuals in a puerperal uterus?
Mazzon I; Favilli A; Grasso M; Horvath S; Gerli S
J Matern Fetal Neonatal Med; 2016; 29(10):1613-6. PubMed ID: 26212585
[TBL] [Abstract][Full Text] [Related]
12. Placenta accreta: conservative approach.
Di Luigi G; Patacchiola F; Di Stefano L; D'Alfonso A; Carta A; Carta G
Clin Exp Obstet Gynecol; 2013; 40(4):596-8. PubMed ID: 24597266
[TBL] [Abstract][Full Text] [Related]
13. Planned conservative management of placenta increta and percreta with prophylactic transcatheter arterial embolization and leaving placenta in situ for women who desire fertility preservation.
Huang KL; Leung-Chit Tsang L; Cheng YF; Huang FJ; Fu HC; Kung FT; Tsai CC; Cheng HH; Lai YJ; Ou CY; Chen WT; Tong YS; Chen YC; Huang YJ; Hsu TY
Placenta; 2020 Aug; 97():51-57. PubMed ID: 32792063
[TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound versus uterine artery embolization for patients with retained placenta accreta.
Jiang J; Wang C; Xue M
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():82-86. PubMed ID: 32590166
[TBL] [Abstract][Full Text] [Related]
15. Pregnancies Following Hysteroscopic Removal of Retained Products of Conception after Delivery Versus Abortion.
Ganer Herman H; Kogan Z; Tairy D; Ben Zvi M; Kerner R; Ginath S; Bar J; Sagiv R
Gynecol Obstet Invest; 2018; 83(6):586-592. PubMed ID: 29945122
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.
Cui R; Li M; Lu J; Bai H; Zhang Z
BMC Pregnancy Childbirth; 2018 Jul; 18(1):298. PubMed ID: 29996794
[TBL] [Abstract][Full Text] [Related]
17. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta.
Bodner LJ; Nosher JL; Gribbin C; Siegel RL; Beale S; Scorza W
Cardiovasc Intervent Radiol; 2006; 29(3):354-61. PubMed ID: 16502171
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
Chen YT; Xu LF; Sun HL; Li HQ; Hu RM; Tan QY
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
[TBL] [Abstract][Full Text] [Related]
19. Conservative management of placenta accreta in a multiparous woman.
Hunt JC
J Pregnancy; 2010; 2010():329618. PubMed ID: 21490740
[TBL] [Abstract][Full Text] [Related]
20. First-trimester abortion complicated with placenta accreta: A systematic review.
Wang YL; Weng SS; Huang WC
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):10-14. PubMed ID: 30638461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
